These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 30817302
1. A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing. Gong LF, Gao X, Yang N, Zhao JQ, Yang HH, Kong YY. J Pediatr Endocrinol Metab; 2019 Mar 26; 32(3):253-258. PubMed ID: 30817302 [Abstract] [Full Text] [Related]
2. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening. Liu SY, Lee CT, Tung YC, Chien YH, Hwu WL, Tsai WY. J Formos Med Assoc; 2018 Feb 26; 117(2):126-131. PubMed ID: 28392195 [Abstract] [Full Text] [Related]
4. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants. Kopacek C, de Castro SM, Prado MJ, da Silva CM, Beltrão LA, Spritzer PM. BMC Pediatr; 2017 Jan 17; 17(1):22. PubMed ID: 28095810 [Abstract] [Full Text] [Related]
5. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants. Güran T, Tezel B, Gürbüz F, Selver Eklioğlu B, Hatipoğlu N, Kara C, Şimşek E, Çizmecioğlu FM, Ozon A, Baş F, Aydın M, Darendeliler F. J Clin Res Pediatr Endocrinol; 2019 Feb 20; 11(1):13-23. PubMed ID: 30111524 [Abstract] [Full Text] [Related]
6. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening. Hird BE, Tetlow L, Tobi S, Patel L, Clayton PE. Arch Dis Child; 2014 Feb 20; 99(2):158-64. PubMed ID: 24225272 [Abstract] [Full Text] [Related]
7. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels. Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A. J Pediatr; 1997 Jan 20; 130(1):128-33. PubMed ID: 9003862 [Abstract] [Full Text] [Related]
8. Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study. Tsuji A, Konishi K, Hasegawa S, Anazawa A, Onishi T, Ono M, Morio T, Kitagawa T, Kashimada K. BMC Pediatr; 2015 Dec 15; 15():209. PubMed ID: 26671474 [Abstract] [Full Text] [Related]
9. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia. Votava F, Török D, Kovács J, Möslinger D, Baumgartner-Parzer SM, Sólyom J, Pribilincová Z, Battelino T, Lebl J, Frisch H, Waldhauser F, Middle European Society for Paediatric Endocrinology -- Congenital Adrenal Hyperplasia (MESPE-CAH) Study Group. Eur J Endocrinol; 2005 Jun 15; 152(6):869-74. PubMed ID: 15941926 [Abstract] [Full Text] [Related]
10. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Therrell BL, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S. Pediatrics; 1998 Apr 15; 101(4 Pt 1):583-90. PubMed ID: 9521938 [Abstract] [Full Text] [Related]
11. High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening. Castro PS, Rassi TO, Araujo RF, Pezzuti IL, Rodrigues AS, Bachega TASS, Silva IN. J Pediatr Endocrinol Metab; 2019 May 27; 32(5):499-504. PubMed ID: 31028712 [Abstract] [Full Text] [Related]
12. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia. Cavarzere P, Samara-Boustani D, Flechtner I, Dechaux M, Elie C, Tardy V, Morel Y, Polak M. Eur J Endocrinol; 2009 Aug 27; 161(2):285-92. PubMed ID: 19451212 [Abstract] [Full Text] [Related]
13. A three-year follow-up of congenital adrenal hyperplasia newborn screening. Pezzuti IL, Barra CB, Mantovani RM, Januário JN, Silva IN. J Pediatr (Rio J); 2014 Aug 27; 90(3):300-7. PubMed ID: 24560529 [Abstract] [Full Text] [Related]
14. Outcome of Newborn Screening for Congenital Adrenal Hyperplasia at Two Time Points. Eshragh N, Doan LV, Connelly KJ, Denniston S, Willis S, LaFranchi SH. Horm Res Paediatr; 2020 Aug 27; 93(2):128-136. PubMed ID: 32659761 [Abstract] [Full Text] [Related]
15. Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing. Janzen N, Riepe FG, Peter M, Sander S, Steuerwald U, Korsch E, Krull F, Müller HL, Heger S, Brack C, Sander J. Horm Res Paediatr; 2012 Aug 27; 77(3):195-9. PubMed ID: 22508345 [Abstract] [Full Text] [Related]
16. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas]. Gu X, Zhou J, Ye J. Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan 27; 36(1):16-8. PubMed ID: 11955341 [Abstract] [Full Text] [Related]
17. Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia. Gleeson HK, Wiley V, Wilcken B, Elliott E, Cowell C, Thonsett M, Byrne G, Ambler G. J Paediatr Child Health; 2008 Oct 27; 44(10):554-9. PubMed ID: 19012627 [Abstract] [Full Text] [Related]
18. Cortisol in dried blood screening specimens from newborns with raised 17-hydroxyprogesterone and congenital adrenal hyperplasia. Mitchell ML, Hermos RJ. Clin Endocrinol (Oxf); 1998 Jun 27; 48(6):757-60. PubMed ID: 9713565 [Abstract] [Full Text] [Related]